Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boon Cher Goh

Showing results (141-150 of 242) with videos related to

Pageof 25
Sort By:
British Journal of Clinical Pharmacology|November 3, 2012
Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patientsPei Jye Voon, Hui Ling Yap, Cho-Yee-Thu Ma, et al.
Journal of Mass Spectrometry : JMS|March 16, 2013
Quantification of L-ergothioneine in human plasma and erythrocytes by liquid chromatography-tandem mass spectrometryLing-Zhi Wang, Win-Lwin Thuya, Dorothy Su-Lin Toh, et al.
Pharmacogenetics and Genomics|August 19, 2011
Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancerNan-Soon Wong, Elaine Zh Seah, Ling-Zhi Wang, et al.
Oncotarget|March 31, 2016
Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its developmentLingzhi Wang, Do Dang Khoa Phan, Jingwen Zhang, et al.
Pharmacogenetics and Genomics|June 14, 2008
Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicityLu Fan, Boon-Cher Goh, Chiung-Ing Wong, et al.
Journal of Extracellular Vesicles|April 17, 2022
Robust delivery of RIG-I agonists using extracellular vesicles for anti-cancer immunotherapyBoya Peng, Trinh Mai Nguyen, Migara Kavishka Jayasinghe, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin doseFeng Zhao, Celine Loke, Sheila Clare Rankin, et al.
JAMA Network Open|February 23, 2023
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint InhibitorsDaniel A Goldstein, Gary M Ginsberg, Dorit Hofnung-Gabbay, et al.
Journal of Hepatology|November 14, 2009
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)Hung Huynh, Van Chanh Ngo, Heng Nung Koong, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2008
Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patientsRoss A Soo, Ling Zhi Wang, Swee Siang Ng, et al.
Pageof 25

Showing results (141-150 of 242) with videos related to

Sort By:
Pageof 25
British Journal of Clinical Pharmacology|November 3, 2012
Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patientsPei Jye Voon, Hui Ling Yap, Cho-Yee-Thu Ma, et al.
Journal of Mass Spectrometry : JMS|March 16, 2013
Quantification of L-ergothioneine in human plasma and erythrocytes by liquid chromatography-tandem mass spectrometryLing-Zhi Wang, Win-Lwin Thuya, Dorothy Su-Lin Toh, et al.
Pharmacogenetics and Genomics|August 19, 2011
Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancerNan-Soon Wong, Elaine Zh Seah, Ling-Zhi Wang, et al.
Oncotarget|March 31, 2016
Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its developmentLingzhi Wang, Do Dang Khoa Phan, Jingwen Zhang, et al.
Pharmacogenetics and Genomics|June 14, 2008
Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicityLu Fan, Boon-Cher Goh, Chiung-Ing Wong, et al.
Journal of Extracellular Vesicles|April 17, 2022
Robust delivery of RIG-I agonists using extracellular vesicles for anti-cancer immunotherapyBoya Peng, Trinh Mai Nguyen, Migara Kavishka Jayasinghe, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin doseFeng Zhao, Celine Loke, Sheila Clare Rankin, et al.
JAMA Network Open|February 23, 2023
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint InhibitorsDaniel A Goldstein, Gary M Ginsberg, Dorit Hofnung-Gabbay, et al.
Journal of Hepatology|November 14, 2009
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)Hung Huynh, Van Chanh Ngo, Heng Nung Koong, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2008
Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patientsRoss A Soo, Ling Zhi Wang, Swee Siang Ng, et al.
Pageof 25